Who Generates More Revenue? Amgen Inc. or Zoetis Inc.

Revenue Showdown: Amgen Inc. vs. Zoetis Inc.

In the ever-evolving landscape of the pharmaceutical industry, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, Amgen Inc. and Zoetis Inc. have been at the forefront, showcasing impressive financial performances. From 2014 to 2023, Amgen Inc. consistently outperformed Zoetis Inc. in revenue generation, with Amgen's revenue growing by approximately 40% over this period. In 2023, Amgen's revenue reached a peak of $28.19 billion, nearly three times that of Zoetis, which stood at $8.54 billion. Despite this disparity, Zoetis has shown remarkable growth, with its revenue increasing by nearly 79% since 2014. This trend highlights Zoetis's expanding footprint in the animal health sector, while Amgen continues to dominate the biotechnology space. As these giants continue to innovate, their financial trajectories offer valuable insights into the future of the pharmaceutical industry.